CD157 enhances malignant pleural mesothelioma aggressiveness and predicts poor clinical outcome.
Ortolan E, Giacomino A, Martinetto F, Morone S, Lo Buono N, Ferrero E, Scagliotti G, Novello S, Orecchia S, Ruffini E, Rapa I, Righi L, Volante M, Funaro A.
Ortolan E, et al.
Oncotarget. 2014 Aug 15;5(15):6191-205. doi: 10.18632/oncotarget.2186.
Oncotarget. 2014.
PMID: 25026285
Free PMC article.